The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
Pharma, biopharma, and medical device makers should watch out for these perennial problems, which include inadequate ...
What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...